[Federal Register Volume 59, Number 139 (Thursday, July 21, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-17695]


[[Page Unknown]]

[Federal Register: July 21, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

Advisory Committee Meeting; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of a meeting of the Nonprescription Drugs 
Advisory Committee, which is scheduled for July 27, 1994. This meeting 
was announced in the Federal Register of June 24, 1994 (59 FR 32699). 
The amendment is being made to reflect a change in the date of the 
meeting from a 1-day to a 2-day meeting and to announce a closed 
portion of the meeting, which is scheduled for the second day and which 
will be held at a location different from that of the open session. The 
open committee discussion remains the same as originally announced. 
This amendment will be announced at the beginning of the open portion 
of the meeting.

FOR FURTHER INFORMATION CONTACT: Lee L. Zwanziger or Mae Brooks, Center 
for Drug Evaluation and Research (HFD-9), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-443-4695.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 24, 1994, 
FDA announced that a meeting of the Nonprescription Drugs Advisory 
Committee would be held on June 27, 1994. On page 32699, in the third 
column, under ``Date, time, and place'' and ``Type of meeting and 
contact person,''  portions of this meeting are amended, and on page 
32700, in the first column, because the committee will now have a 
closed portion on July 28, 1994, a  ``Closed committee deliberations''  
paragraph is added to read as follows:
    Date, time, and place. July 27, 1994, 2 p.m., Parklawn Bldg., 
conference rms. D and E, 5600 Fishers Lane, Rockville, MD, and July 28, 
1994, 8:30 a.m., Montrose Room, Ramada Inn, 1775 Rockville Pike, 
Rockville, MD.
    Type of meeting and contact person. Open public hearing, July 27, 
1994, 2 p.m. to 3 p.m., unless public participation does not last that 
long; open committee discussion, 3 p.m. to 6 p.m.; closed committee 
deliberations, July 28, 1994, 8:30 a.m. to 12 m.; Lee L. Zwanziger or 
Mae Brooks, Center for Drug Evaluation and Research (HFD-9), Food and 
Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-
4695.
    Closed committee deliberations. On July 28, 1994, the committee 
will discuss trade secret and/or confidential commercial information 
relevant to pending NDA's. This portion of the meeting will be closed 
to permit discussion of this information (5 U.S.C. 552b(c)(4)).

    Dated: July 14, 1994.
 Linda A. Suydam,
 Interim Deputy Commissioner for Operations.
[FR Doc. 94-17695 Filed 7-20-94; 8:45 am]
BILLING CODE 4160-01-F